Expression of SART3 Tumor‐rejection Antigen in Gastric Cancers

We previously reported SART3 as a tumor‐rejection antigen recognized by histocompatibility leukocyte antigen (HLA)‐A24‐restricted cytotoxic T lymphocytes (CTLs). In this study, we investigated the expression of the SART3 antigen in gastric cancers, as a candidate for use in specific immunotherapy. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Niiya, Fumihiko, Nishizaka, Shinya, Matsunaga, Kazuko, Koufuji, Kikuo, Mori, Masaki, Katai, Hitoshi, Yamana, Hideaki, Itoh, Kyogo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2000
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926363/
https://www.ncbi.nlm.nih.gov/pubmed/10760694
http://dx.doi.org/10.1111/j.1349-7006.2000.tb00950.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926363/
https://www.ncbi.nlm.nih.gov/pubmed/10760694
http://dx.doi.org/10.1111/j.1349-7006.2000.tb00950.x

Ejemplares similares